Santral Seröz Koryoretinopati

Van Rijsen TJ, Van Dijk EHC, Yzer S, et al.Central serous chorioretinopathy: To- wards an evidence-based treatment guideline.Progress in Retinal and Eye Research. 2019;73:100770.

Salmon JF. Kanski Klinik Oftalmoloji. 2021.Bölüm 14.Akkiz Maküla Hastalıkları.s 598- 600.

Kitzmann, AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinop- athy in Olmsted Country, Minnesota, 1980-2002. Ophthalmology 2008;115 (1):169-73.

Breukink MB, Dingemans AJ, Hollander AE, et al. Chronic central serous chorioret- inopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol 2017;11:39-46.

Sahin A, Bez Y, Kaya MC, et al.Psychological distress and poor quality of life in patients with central serous chorioretinopathy.Semin. Ophtalmol.2014;29,73-6.

Singh SR, Matet A, vanDijk EHC, Daruich A, Fauser S, Yzer S, et al.Disprepancy in cur- rent central serous chorioretinopathy classification. Br J Ophthalmol.2019;103:737-42.

Gilbert CM, Owens SL, Smith PD, et al.Long-term follow-up of central serous chorioret- inopathy. Br J Ophthalmol .1984;68 (11),815-20.

Gackle HC, Lang GE, Freissler KA, et al. Central serous chorioretinopathy .Clinical, flu- orescein angiography and demographic aspects.Ophthalmologe .1998;95(8):529-33.

Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy:A Systematic Review and Meta-Analysis. Retina.2016;36(1):9-19.

Wong KH, Lau KP, Chhablani J , et al. Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol. 2016;94:321-5.

Prakash G, Chauhan N, Jain S, Satsangi SK.Central serous chorioretinopathy: A Review of the Literature. Asia Pac J Ophthalmol (Phila). 2013;2:104-10

Cheung CMG, Lee WK, Kouzumi H, et al. Pachychoroid disease.Eye (Lond) 2019;33(1):18-33.

Daruich A, Matet A, Marchionni L, De Azevedo JD, Ambresin A, Mantel I, Behar-Co- hen F, 2017:Acute central serous chorioretinopathy:factors influencing episode duration. Retina 37.1905- 15.

Liu DT, Fok AT, Lam DSC. An Update on the Diagnosos and Management of Central Serous Chorioretinopathy. Asia-Pacific J Ophthalmol.2012;1(5):296-302.

Prakash G, Chauhan N, Jain S, Satsangi SK. Central Serous Chorioretinopathy: A Review of the Literature.Asia-Pasific J Ophthalmol.2013;2(2):104-110.

Iacono P, Battaglia Parodi M, Falcomata B, Bandello F. Central Serous Chorioretinopathy treatments: A mini review. Ophtalmic Res.2015;55:76-83.

Loo H, Scott IU, Flynn HW, et al.Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002;22(1):19-24.

Bujarborua D, Napgal PN, Deka M.Smokestack leak in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol.2010;248(3):339- 351.

Spitnaz M, Huke J. Number, shape and topography of leakege points in acute type 1 cen- tral serous retinopathy.Graefes Arch Clin Exp Ophthalmol 1987;225(6):437-40.

Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central Serous Chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res.2015;48:82-118.

Ayata A, Tatlipinar S, Kar T, Unal M,Ersanli D, Bilge AH.Near infrared and short-wave- length autofluorescence imaging in central serous chorioretinopathy.Br J Ophthal- mol.2009;93(1):79-82.

Framme C, Walter A, Gabler B, et al.Fundus autofluorescence in acute and chronic –re- current central serous chorioretinopathy.Acta Ophthalmol Scand 2005;83(2):161-7.

Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.Retina 2009;29(10):1469- 1473.

Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.Retina 2011;31(8):1603-1608.

Teke MY, Elgin U, Nalçacıoğlu P, et al. Comparison of autofluorescence and optical co- herence tomography findings in acute and chronic central serous chorioretinopathy. Int.J. Ophthalmol 2014;7(2):350-4.

Cakir B, Reich M, Lang S, et al. OCT Angiography of the Choriocapillaris in central se- rous Chorioretinopathy: A Quantitative Subgroup Analysis. Ophthalmol Ther. January 2019.

Yaylacıoğlu TF, Gürelik G. Santral Seröz Koryoretinopati.Ret-Vit 2010;18:85-111

Manayath GJ, Ranjan R, Karandikar SS, et al. Central serous chorioretinopathy: Current update on management. Oman J Ophthalmol.2018;11:200-6.

Robertson DM, Ilstrup D. Direct,indirect and sham laser photocoagulation in the man- agement of central serous chorioretinopathy.Am J Ophthalmol 1983;95:457-66.

Chan WM, Lam DS, Lai TY, et al.Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green angiography guided photodynamic ther- apy with verteporfin: a novel treatment at the primary disease level.Br J Ophthalmol.2003;87:1453-8.

Wuarin R, Kakkassery V, Consigli A, et al. Combined Topical anti- inflammatory and oral acetozolamide in the treatment of central serous chorioretinopathy. Optom Vis Sci.2019;96:500-6.

Yadav NK, Jayadev C, Mohan A, et al.Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.Eye 2015;29:258-65.